A Research Study of the New Medicine NNC0519-0130 in Male Chinese Participants Living With Excess Body Weight

by | Jun 4, 2025 | Clinical Trials | 0 comments

​ Conditions: Diabetes Mellitus, Type 2; Obesity

Interventions: Drug: NNC0519-0130; Drug: Placebo

Sponsors: Novo Nordisk A/S

Not yet recruiting Conditions: Diabetes Mellitus, Type 2; Obesity
Interventions: Drug: NNC0519-0130; Drug: Placebo
Sponsors: Novo Nordisk A/S
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *